Sophie Susen

11.0k total citations · 2 hit papers
168 papers, 4.5k citations indexed

About

Sophie Susen is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Surgery. According to data from OpenAlex, Sophie Susen has authored 168 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Cardiology and Cardiovascular Medicine, 60 papers in Hematology and 46 papers in Surgery. Recurrent topics in Sophie Susen's work include Platelet Disorders and Treatments (38 papers), Venous Thromboembolism Diagnosis and Management (24 papers) and Antiplatelet Therapy and Cardiovascular Diseases (21 papers). Sophie Susen is often cited by papers focused on Platelet Disorders and Treatments (38 papers), Venous Thromboembolism Diagnosis and Management (24 papers) and Antiplatelet Therapy and Cardiovascular Diseases (21 papers). Sophie Susen collaborates with scholars based in France, United States and Switzerland. Sophie Susen's co-authors include Brigitte Jude, André Vincentelli, Françis Juthier, Éric Van Belle, Thierry Le Tourneau, Jenny Goudemand, Alain Prat, Anne Bauters, Olivier Fabre and Antoine Rauch and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Sophie Susen

153 papers receiving 4.4k citations

Hit Papers

Acquired von Willebrand Syndrome in Aortic Stenosis 2003 2026 2010 2018 2003 2023 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophie Susen France 35 1.7k 1.4k 1.0k 760 635 168 4.5k
Kenichi A. Tanaka United States 41 1.7k 1.0× 1.9k 1.4× 2.0k 2.0× 817 1.1× 1.0k 1.6× 269 7.5k
Ian J. Welsby United States 34 1.5k 0.8× 1.6k 1.2× 693 0.7× 461 0.6× 558 0.9× 141 3.9k
Harold L. Dauerman United States 34 2.5k 1.4× 1.8k 1.3× 275 0.3× 263 0.3× 455 0.7× 138 4.6k
Brigitte Jude France 34 1.4k 0.8× 1.7k 1.2× 1.2k 1.2× 616 0.8× 433 0.7× 133 5.7k
Ekaterina Baryshnikova Italy 27 765 0.4× 715 0.5× 351 0.4× 313 0.4× 580 0.9× 81 2.8k
Larry W. Kraiss United States 36 1.4k 0.8× 2.0k 1.4× 1.0k 1.0× 173 0.2× 472 0.7× 122 5.1k
Pierre Fontana Switzerland 37 2.1k 1.2× 1.0k 0.7× 869 0.9× 87 0.1× 1.1k 1.7× 200 4.5k
Lorenzo Menicanti Italy 40 4.5k 2.6× 3.3k 2.4× 192 0.2× 1.2k 1.5× 348 0.5× 196 6.9k
Lorenzo Alberio Switzerland 30 752 0.4× 748 0.5× 1.8k 1.8× 85 0.1× 716 1.1× 169 3.8k
Sherrill J. Slichter United States 46 1.0k 0.6× 1.2k 0.9× 4.6k 4.6× 209 0.3× 645 1.0× 135 8.1k

Countries citing papers authored by Sophie Susen

Since Specialization
Citations

This map shows the geographic impact of Sophie Susen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Susen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Susen more than expected).

Fields of papers citing papers by Sophie Susen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Susen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Susen. The network helps show where Sophie Susen may publish in the future.

Co-authorship network of co-authors of Sophie Susen

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Susen. A scholar is included among the top collaborators of Sophie Susen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Susen. Sophie Susen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Godiér, Anne, Alexandre Mansour, Delphine Garrigue, & Sophie Susen. (2025). Fibrinogen: the higher the better?. PubMed. 23(1). 79–82.
2.
Godiér, Anne, Dominique Lasne, Anne‐Céline Martin, et al.. (2025). Management of bleeding and invasive procedures in patients treated with anti–factor XI(a) anticoagulants: proposals from the French Working Group on Perioperative Haemostasis and French Society of Thrombosis and Haemostasis. Research and Practice in Thrombosis and Haemostasis. 9(3). 102860–102860. 2 indexed citations
3.
Susen, Sophie, Marc Trossaërt, Moshe Zilberstein, et al.. (2025). A phase 1, open-label study to assess the pharmacokinetics, safety, and tolerability of a single intravenous injection of efanesoctocog alfa in adults with type 2N or type 3 von Willebrand disease. Journal of Thrombosis and Haemostasis. 24(1). 79–87. 2 indexed citations
4.
Heestermans, Marco, Ivan Peyron, Marie‐Annick Clavel, et al.. (2024). A fully humanized von Willebrand disease type 1 mouse model as unique platform to investigate novel therapeutic options. Haematologica. 110(4). 923–937. 4 indexed citations
6.
Iba, Toshiaki, Jerrold H. Levy, Jecko Thachil, et al.. (2023). Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasis on vascular endothelium-related biomarkers in disseminated intravascular coagulation. Journal of Thrombosis and Haemostasis. 21(3). 691–699. 20 indexed citations
7.
Poulain, Stéphanie, Emmanuelle Jeanpierre, Micha Srour, et al.. (2022). Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider. Leukemia & lymphoma. 63(13). 3100–3104. 1 indexed citations
8.
Gaudet, Alexandre, Annabelle Dupont, Erika Parmentier-Decrucq, et al.. (2022). Derivation and Validation of a Predictive Score for Respiratory Failure Worsening Leading to Secondary Intubation in COVID-19: The CERES Score. Journal of Clinical Medicine. 11(8). 2172–2172. 4 indexed citations
9.
Lassalle, Fanny, Mickaël Rosa, Bart Staels, et al.. (2022). Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement. International Journal of Molecular Sciences. 23(10). 5303–5303. 7 indexed citations
10.
Denis, Cécile V., Sophie Susen, & Peter J. Lenting. (2021). von Willebrand disease: what does the future hold?. Blood. 137(17). 2299–2306. 20 indexed citations
11.
Loyau, Stéphane, D. Yu. Nechipurenko, Nicolas Receveur, et al.. (2020). Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin. Arteriosclerosis Thrombosis and Vascular Biology. 40(9). 2127–2142. 50 indexed citations
12.
Lassalle, Fanny, Loubna Jouan, Laura L. Swystun, et al.. (2020). The challenge of genetically unresolved haemophilia A patients: Interest of the combination of whole F8 gene sequencing and functional assays. Haemophilia. 26(6). 1056–1063. 11 indexed citations
13.
Piérache, Adeline, Anne Bauters, Antoine Rauch, et al.. (2019). Hemostatic profile of infants with spontaneous prematurity: can we predict intraventricular hemorrhage development?. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 45(1). 113–113. 10 indexed citations
15.
Sottejeau, Yoann, Delphine Corseaux, Françis Juthier, et al.. (2019). Valvular interstitial cells down regulate matrix metalloproteinase 9 activity and expression in human monocyte-derived macrophages: Potential impact on aortic valve stenosis pathophysiology. Archives of Cardiovascular Diseases Supplements. 11(2). 248–248. 1 indexed citations
16.
Ivanés, Fabrice, Sophie Susen, Frédéric Mouquet, et al.. (2011). Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. European Heart Journal. 33(2). 191–202. 100 indexed citations
17.
Vincentelli, André, Fabrice Wautot, Françis Juthier, et al.. (2007). In vivo autologous recellularization of a tissue-engineered heart valve: Are bone marrow mesenchymal stem cells the best candidates?. Journal of Thoracic and Cardiovascular Surgery. 134(2). 424–432. 63 indexed citations
18.
Juthier, Françis, André Vincentelli, Julien Gaudric, et al.. (2006). Decellularized heart valve as a scaffold for in vivo recellularization: Deleterious effects of granulocyte colony-stimulating factor. Journal of Thoracic and Cardiovascular Surgery. 131(4). 843–852. 33 indexed citations
19.
Jude, Brigitte, Anne Bauters, Julien Gaudric, et al.. (2004). Hémostase et hypothermie. Sang thrombose vaisseaux. 16(10). 515–519. 2 indexed citations
20.
Susen, Sophie, Karine Sautière, Christophe Zawadzki, et al.. (2003). Tissue factor predicts long-term outcome after percutaneous coronary revascularization. Journal of the American College of Cardiology. 41(6). 69–69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026